Expense

Achillion Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, August 8, 2019
Health, Clinical research, Drug Safety, Investigational New Drug, Expense, Food and Drug Administration

The full data set is expected in the fourth quarter of 2019.

Key Points: 
  • The full data set is expected in the fourth quarter of 2019.
  • The Company expects to submit an investigational new drug (IND) application to the FDA for ACH-5228 in the fourth quarter of 2019.
  • Non-cash stock compensation expense totaled $1.9 million for the second quarter of 2019 as compared with $3.5 million for the second quarter of 2018 and is included in research and development expenses and general and administrative expenses.
  • Achillion disclaims any duty to update any forward-looking statement, except as required by applicable law.

EURO Ressources reports earnings for the second quarter and six months ended June 30, 2019

Retrieved on: 
Thursday, August 8, 2019
Tax accounting, Expense, Tax expense

Under French GAAP, EURO reported a net profit of 8.3million (0.132per share) for the six months ended June30, 2019 compared to 8.5million (0.137per share) for the six months ended June30, 2018.

Key Points: 
  • Under French GAAP, EURO reported a net profit of 8.3million (0.132per share) for the six months ended June30, 2019 compared to 8.5million (0.137per share) for the six months ended June30, 2018.
  • No impairment charges were recorded in the statement of earnings for the second quarter ended June 30, 2019.
  • During the first six months ended June30, 2019, EURO recorded an income tax expense of 3.9million compared to 3.6million during the six months ended June 30, 2018.
  • EURO recorded an income tax expense of 1.8million in the second quarter of 2019 compared to 2.3million in the second quarter of 2018.

Bellatrix Exploration Ltd. Announces Second Quarter 2019 Financial and Operating Results

Retrieved on: 
Wednesday, August 7, 2019
Economy, Accounting, Fundamental analysis, Expense, Business, Intellectual property law, Patent law, Royalty payment, Operating cash flow, Revenue, Cash flow

A conference call to discuss Bellatrix's second quarter results will be held on August 8, 2019 at 9:00 am MT / 11:00 am ET.

Key Points: 
  • A conference call to discuss Bellatrix's second quarter results will be held on August 8, 2019 at 9:00 am MT / 11:00 am ET.
  • Operating netbacks are calculated by subtracting royalties, transportation, and operating expenses from total revenue.
  • Management believes this measure is a useful supplemental measure of the amount of total revenue received after transportation, royalties and operating expenses.
  • The reconciliation between cash flow from operating activities and adjusted funds flow can be found in the MD&A.

Bancorp of New Jersey Reports 2019 Second Quarter Financial Results

Retrieved on: 
Wednesday, August 7, 2019
Expense, Interest expense

During the six months ended June 30, 2019, interest income increased by $1.7 million or 9.8% versus the same period last year.

Key Points: 
  • During the six months ended June 30, 2019, interest income increased by $1.7 million or 9.8% versus the same period last year.
  • Total interest expense increased by $1.1 million in the second quarter of 2019 to $3.3 million compared to $2.2 million in the prior year period.
  • During the six months ended June 30, 2019, interest expense increased by $2.1 million versus the same period last year.
  • Net income for the second quarter of 2019 was $1.34 million compared to net income of $1.19 million for the second quarter of 2018, an increase of $155,000 or 13.0%.

Half of hospital decision makers plan to invest in AI by 2021, study shows

Retrieved on: 
Wednesday, August 7, 2019
Expense, Insurance, Reimbursement, Tax, Hospital

However, the digitization of healthcare and the complexities of reimbursement are fundamentally changing the way hospital data is managed, adding new layers of administrative processes.

Key Points: 
  • However, the digitization of healthcare and the complexities of reimbursement are fundamentally changing the way hospital data is managed, adding new layers of administrative processes.
  • The result: increasing operational expenses across hospitals and health systems.
  • A recent study conducted by Olive AI explores how hospital leaders are responding to the imperative to drive efficiency and reduce costs through strategic investments in non-clinical technologies.
  • Olive conducted this survey in partnership with Sage Growth Partners, an independent healthcare market research, consulting and marketing firm.

XOMA Reports Second Quarter 2019 Royalty Asset Portfolio Highlights and Financial Results

Retrieved on: 
Tuesday, August 6, 2019
Expense, Intellectual property law, Patent law, Royalty payment

Royalty and milestone interest acquired in five anti-thrombotic hematology assets from Aronora, Inc.

Key Points: 
  • Royalty and milestone interest acquired in five anti-thrombotic hematology assets from Aronora, Inc.
    EMERYVILLE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA), today announced its second quarter 2019 royalty asset portfolio highlights and financial results.
  • XOMA recorded total revenues of $1.0 million for the second quarter of 2019, compared with $2.3 million recorded for the second quarter of 2018.
  • General and administrative expenses were $4.9 million for the second quarter of 2019, compared to $4.4 million for the second quarter of 2018.
  • Net loss for the second quarter of 2019 was $4.1 million, compared to $1.9 million for the second quarter of 2018.

Freehold Royalties Ltd. Announces Second Quarter Results & Increases Production Guidance

Retrieved on: 
Thursday, August 1, 2019
Expense, Royalty payment, Forward-looking statement

We caution that it is inherently difficult to predict activity levels on our royalty lands since we have no operational control.

Key Points: 
  • We caution that it is inherently difficult to predict activity levels on our royalty lands since we have no operational control.
  • Our actual results, performance, or achievement could differ materially from those expressed in, or implied by, these forward-looking statements.
  • To provide a single unit of production for analytical purposes, natural gas production and reserves volumes are converted mathematically to equivalent barrels of oil (boe).
  • For Freehold cash costs are identified as operating expense, general and administrative expense, interest expense and share based compensation payments.

Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, August 1, 2019
Corporate finance, Expense, SG&A, Employee stock option, G&A

Operating Expenses: GAAP operating expenses were $11.8 million for the second quarter of 2019, compared to $13.8 million for the second quarter of 2018.

Key Points: 
  • Operating Expenses: GAAP operating expenses were $11.8 million for the second quarter of 2019, compared to $13.8 million for the second quarter of 2018.
  • Non-GAAP operating expenses, which exclude stock-based compensation, were $10.6 million for the second quarter of 2019, compared to $9.4 million for the second quarter of 2018.
  • Research and Development Expenses: GAAP research and development (R&D) expenses for the second quarter of 2019 were $8.9 million, compared to $8.2 million for the second quarter of 2018.
  • Selling, General and Administrative Expenses: GAAP selling, general and administrative (SG&A) expenses in the second quarter of 2019 were $2.9 million, compared to $5.6 million for the second quarter of 2018.

Dorchester Minerals, L.P. Announces Second Quarter Results

Retrieved on: 
Thursday, August 1, 2019
Expense, Oil and gas law, Economy, Energy in the United States, Oil and gas law in the United States, United States contract law, Royalty payment, Net profit, Net income, Depletion, Profit, Property law

The Partnership previously declared its second quarter distribution in the amount of $0.515016 per common unit payable on August 8, 2019 to common unit holders of record as of July 29, 2019.

Key Points: 
  • The Partnership previously declared its second quarter distribution in the amount of $0.515016 per common unit payable on August 8, 2019 to common unit holders of record as of July 29, 2019.
  • The Partnerships cash distributions are not comparable to its net earnings due to timing and other differences including depletion.
  • Dorchester Minerals, L.P. is a Dallas based owner of producing and non-producing oil and natural gas mineral, royalty, overriding royalty, net profits, and leasehold interests located in 27 states.
  • Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected.

Agios Reports Business Highlights and Second Quarter 2019 Financial Results

Retrieved on: 
Thursday, August 1, 2019
Expense, SG&A, G&A

Research and Development (R&D) Expenses: R&D expenses were $107.4 million for the second quarter of 2019 compared to $86.7 million for the second quarter of 2018.

Key Points: 
  • Research and Development (R&D) Expenses: R&D expenses were $107.4 million for the second quarter of 2019 compared to $86.7 million for the second quarter of 2018.
  • Selling, General and Administrative (SG&A) Expenses: SG&A expenses were $32.4 million for the second quarter of 2019 compared to $26.6 million for the second quarter of 2018.
  • Net Loss: Net loss was $109.9 million for the second quarter of 2019 compared to $68.7 million for the second quarter of 2018.
  • ET to discuss second quarter 2019 financial results and recent business activities.